Multiple sclerosis journal - experimental, translational and clinical

· 4 papers in corpus
observational 2026
Comorbidities in newly diagnosed multiple sclerosis patients: A population-based register study in Finland
doi:10.1177/20552173251411076 ·PMID:41552666

BACKGROUND: Comorbidities are common among people with multiple sclerosis (pwMS) and have been suggested to affect the usage of disease-modifying treatments (DMTs). OBJECTIVES: We investigated the prevalence and types of comorbidities in n…

observational 2024
A comparative study of fatigue and processing speed in patients with multiple sclerosis treated with natalizumab or rituximab.
doi:10.1177/20552173241252566 ·PMID:38807848

BackgroundFatigue is the most debilitating symptom in patients with multiple sclerosis (MS). Natalizumab and rituximab are the most used MS disease modifying therapies in Sweden, but comparative data on the effect on fatigue is sparse.Objec…

nonrandomized-trial 2022
Trans-anal irrigation in patients with multiple sclerosis: Efficacy in treating disease-related bowel dysfunctions and impact on the gut microbiota: A monocentric prospective study
doi:10.1177/20552173221109771 ·PMID:35832690

BACKGROUND: Constipation and faecal incontinence are not so uncommon in patients with multiple sclerosis, impairing quality of life. The gut microbiota is altered in multiple sclerosis patients and likely contributes to disease pathogenesis…

observational 2021
The road to conception for women with multiple sclerosis.
doi:10.1177/20552173211032313 ·PMID:34350028

ObjectiveThe objective of this prospective "real world" study is to gain insight into the different "roads to conception" that women with MS take as part of the prospective Canadian Multiple Sclerosis Pregnancy Study (CANPREG-MS).MethodsPar…